2022 - PRESS RELEASES Written on 16 February 2022. Posted in GFB'S Press Releases . Atamyo Therapeutics Reaches Significant Regulatory and Financial Milestones for ATA-100, its Gene Therapy to Treat Limb-Girdle Muscular Dystrophy Type 2I/R9 - Atamyo.com escludi Hits: 1981 Next
